Related references
Note: Only part of the references are listed.Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Huaqin Lin et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer
Jung Min Kim et al.
DISEASES OF THE COLON & RECTUM (2020)
Efficacy and safety of wait and see strategy versus radical surgery and local excision for rectal cancer with cCR response after neoadjuvant chemoradiotherapy: a meta-analysis
Guo-hua Zhao et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Analysis of long-term oncological results of clinical versus pathological responses after neoadjuvant treatment in locally advanced rectal cancer
Mariana F. Coraglio et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Radioprotective effects of mistletoe extract in zebrafish embryos in vivo
Chai Hong Rim et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)
Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma In Vitro and In Vivo in Glioblastoma Bearing Mice
Sonja Schoetterl et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low-Risk, Locally Advanced Rectal Cancer (RaP Study/STAR-03)
Carmine Pinto et al.
ONCOLOGIST (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study
Florian Pelzer et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2018)
Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study
L. Xu et al.
COLORECTAL DISEASE (2017)
Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer A Meta-analysis of Published Studies
Fausto Petrelli et al.
ANNALS OF SURGERY (2016)
Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation
Christian P. Probst et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Carmen J. Allegra et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204
Jerome C. Landry et al.
ONCOLOGIST (2015)
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Carmen J. Allegra et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04
Michael J. O'Connell et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Comparison of Tumor Regression Grade Systems for Locally Advanced Rectal Cancer After Multimodality Treatment
Atthaphorn Trakarnsanga et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
COMPARATIVE STUDY CONCERNING MISTLETOE VISCOTOXINS ANTITUMOR ACTIVITY
Roxana Liana Stan et al.
ACTA BIOLOGICA HUNGARICA (2013)
Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07
D. Helbling et al.
ANNALS OF ONCOLOGY (2013)
Neoadjuvant Radiotherapy for Rectal Cancer: Meta-analysis of Randomized Controlled Trials
Nuh N. Rahbari et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Neoadjuvant treatment of mid-to-lower rectal cancer with oxaliplatin plus 5-fluorouracil and leucovorin in combination with radiotherapy: a Korean single center phase II study
Won-Suk Lee et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2013)
P02.116. The relationship between deqi and the effect of acupuncture
Y Choi et al.
BMC Complementary and Alternative Medicine (2012)
Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)
Alice Dewdney et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
Jean-Pierre Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
Rolf Sauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
Ralf-Dieter Hofheinz et al.
LANCET ONCOLOGY (2012)
The current landscape of locally advanced rectal cancer
Mebea Aklilu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients: A Systematic Review of Controlled Clinical Studies
Gunver S. Kienle et al.
INTEGRATIVE CANCER THERAPIES (2010)
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
Monique Maas et al.
LANCET ONCOLOGY (2010)
Cytotoxic Effect of Mistletoe (Viscum album L.) Extract on Jurkat Cells and its Interaction with Doxorubicin
Lucia Sabova et al.
PHYTOTHERAPY RESEARCH (2010)
Mistletoe Lectin-I Augments Antiproliferative Effects of the PPARγ Agonist Rosiglitazone on Human Malignant Melanoma Cells
Christian Freudlsperger et al.
PHYTOTHERAPY RESEARCH (2010)
Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03
Mark S. Roh et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers:: Results of FFCD 9203
Jean-Pierre Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemotherapy with preoperative radiotherapy in rectal cancer
Jean-Francois Bosset et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Evaluation of the hypoglycemic effect and antioxidant activity of three Viscum album subspecies (European mistletoe) in streptozotocin-diabetic rats
DD Orhan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2005)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Antitumor activity of the Korean mistletoe lectin is attributed to activation of macrophages and NK cells
TJ Yoon et al.
ARCHIVES OF PHARMACAL RESEARCH (2003)
T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival
G Theodoropoulos et al.
DISEASES OF THE COLON & RECTUM (2002)
Share Paper
